New York State Common Retirement Fund Puma Biotechnology, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 3,600 shares of PBYI stock, worth $10,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,600
Previous 3,600
-0.0%
Holding current value
$10,296
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding PBYI
# of Institutions
107Shares Held
32.2MCall Options Held
43.4KPut Options Held
3.7K-
Vanguard Group Inc Valley Forge, PA3.64MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$10.2 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.06MShares$8.76 Million0.42% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.45MShares$7.01 Million6.49% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$5.64 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $130M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...